BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tojyo I, Yamaguti A, Ozaki H, Yoshida H, Fujita S. The expression of fibroblast growth factor receptor-3 in synovial osteochondromatosis of the temporomandibular joint. Arch Oral Biol. 2004;49:591-594. [PMID: 15126141 DOI: 10.1016/j.archoralbio.2003.12.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yoshida H, Tsuji K, Ishikawa H, Nakayama M, Yamamoto M, Takasugi N, Ikeda H, Kitayoshi M, Tani M, Iseki T, Ueda K, Tamura I. Scanning electoronmicroscopical analysis of the loose bodies of synovial chondoromatosis in temporomandibular joint. Med Mol Morphol 2020;53:82-5. [PMID: 31820106 DOI: 10.1007/s00795-019-00235-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Campbell DI, De Silva RK, De Silva H, Sinon SH, Rich AM. Temporomandibular joint synovial chondromatosis with intracranial extension: a review and observations of patient observed for 4 years. J Oral Maxillofac Surg. 2011;69:2247-2252. [PMID: 21292373 DOI: 10.1016/j.joms.2010.10.042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
3 Guijarro-Martínez R, Puche Torres M, Marqués Mateo M, Solís García I, Miragall Alba L, Iglesias Gimilio ME, Pérez-Herrezuelo Hermosa G, Pascual Gil JV. Bilateral synovial chondromatosis of the temporomandibular joint. J Craniomaxillofac Surg 2011;39:261-5. [PMID: 20605727 DOI: 10.1016/j.jcms.2010.04.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
4 Li Y, Cai H, Fang W, Meng Q, Li J, Deng M, Long X. Fibroblast growth factor 2 involved in the pathogenesis of synovial chondromatosis of temporomandibular joint. J Oral Pathol Med 2014;43:388-94. [PMID: 24372705 DOI: 10.1111/jop.12146] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
5 Wake S, Yoshitake H, Kayamori K, Izumo T, Harada K. Expression of CD90 decreases with progression of synovial chondromatosis in the temporomandibular joint. Cranio 2016;34:250-6. [PMID: 26292970 DOI: 10.1179/2151090315Y.0000000020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
6 Nimeskern N, Gleizal A, Geha H, Béziat J. Ostéochondromatose synoviale de l’articulation temporomandibulaire. Revue de Stomatologie et de Chirurgie Maxillo-faciale 2006;107:483-5. [DOI: 10.1016/s0035-1768(06)77094-2] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
7 Wilms CT, Heim N, Teschke M, Reich RR, Götz W. Synovial chondromatosis of the temporomandibular joint: Immunohistochemical examinations regarding the role of insulin-like growth factors and their binding proteins in the etiology of this disease. Journal of Cranio-Maxillofacial Surgery 2017;45:198-202. [DOI: 10.1016/j.jcms.2016.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Wake M, Hamada Y, Kumagai K, Tanaka N, Ikeda Y, Nakatani Y, Suzuki R, Fukui N. Up-regulation of interleukin-6 and vascular endothelial growth factor-A in the synovial fluid of temporomandibular joints affected by synovial chondromatosis. British Journal of Oral and Maxillofacial Surgery 2013;51:164-9. [DOI: 10.1016/j.bjoms.2012.03.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
9 Li Y, El Mozen LA, Cai H, Fang W, Meng Q, Li J, Deng M, Long X. Transforming growth factor beta 3 involved in the pathogenesis of synovial chondromatosis of temporomandibular joint. Sci Rep. 2015;5:8843. [PMID: 25742744 DOI: 10.1038/srep08843] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
10 Romero N, Mulcahy CF, Barak S, Shand MF, Badger CD, Joshi AS. Synovial osteochondromatosis of the temporomandibular joint: A case report. WJO 2019;8:12-8. [DOI: 10.5319/wjo.v8.i2.12] [Reference Citation Analysis]
11 Shah SB, Ramanojam S, Gadre PK, Gadre KS. Synovial chondromatosis of temporomandibular joint: journey through 25 decades and a case report. J Oral Maxillofac Surg. 2011;69:2795-2814. [PMID: 21470750 DOI: 10.1016/j.joms.2010.12.029] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
12 Li B, Long X, Cheng Y, Yang X, Li X, Cai H. Ultrasonographic and arthrographic diagnoses of synovial chondromatosis. Dentomaxillofacial Radiology 2007;36:175-9. [DOI: 10.1259/dmfr/32238405] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
13 Lieger O, Zix J, Stauffer-brauch EJ, Iizuka T. Synovial Chondromatosis of the Temporomandibular Joint With Cranial Extension: A Case Report and Literature Review. Journal of Oral and Maxillofacial Surgery 2007;65:2073-80. [DOI: 10.1016/j.joms.2006.04.039] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
14 Okamura G, Ebina K, Hirao M, Chijimatsu R, Yonetani Y, Etani Y, Miyama A, Takami K, Goshima A, Yoshikawa H, Ishimoto T, Nakano T, Hamada M, Kanamoto T, Nakata K. Promoting Effect of Basic Fibroblast Growth Factor in Synovial Mesenchymal Stem Cell-Based Cartilage Regeneration. Int J Mol Sci 2020;22:E300. [PMID: 33396695 DOI: 10.3390/ijms22010300] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kim JH, Lee MC, Seong SC, Park KH, Lee S. Enhanced Proliferation and Chondrogenic Differentiation of Human Synovium-Derived Stem Cells Expanded with Basic Fibroblast Growth Factor. Tissue Engineering Part A 2011;17:991-1002. [DOI: 10.1089/ten.tea.2010.0277] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]